Zydus Lifesciences, an Indian life sciences company, has announced the commencement of Phase IV Real World Data Registry trial “EVIDENCES-XI” for Saroglitazar Magnesium (Mg) in patients with non-alcoholic fatty liver disease (NAFLD) and comorbidities. This late-stage trial aims to evaluate the efficacy of Saroglitazar Mg in approximately 1,500 male and female NAFLD patients, each with […]
Cadila Healthcare (Zydus Cadilla) said that it has obtained permission from the US Food and Drug Administration (FDA) to launch the phase 2(b)/3 clinical trial of saroglitazar magnesium in primary biliary cholangitis (PBC). The late-stage trial, designed to assess the efficacy and safety of saroglitazar magnesium, will have 192 patients. The participants will be randomly […]
